Skip to main content
Fig. 4 | Parasites & Vectors

Fig. 4

From: Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) in the prevention of feline Aelurostrongylus abstrusus infection evaluated in a multi-diagnostic approach

Fig. 4

Lung severity scores of the investigational veterinary product (IVP)-treated groups (Bravecto® Plus spot-on, minimum recommended dose of 40 mg fluralaner and 2.0 mg moxidectin/kg body weight; G1, G2, G3) and the control group (0.9% saline, G4). Comparison of lung severity scores of the treatment groups with the control group by two-sided Wilcoxon rank-sum test. G1: treatment 12 weeks prior to inoculation; G2: treatment 8 weeks prior to inoculation; G3: treatment 4 weeks prior to inoculation

Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us